Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.…
How Much Upside is Left in Lumexa (LMRI)? Wall Street Analysts Think 30.84%
Lumexa Imaging Holdings (NASDAQ: LMRI) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 5,000 employees.
The shares were at 14.26 USD on 20 November 2026. Its 52-week range is 6.450 USD to 19.45 USD: the price is 26.7% below the high and 121.1% above the low.
Its market capitalisation is 1.37B USD.
Lumexa Imaging Holdings reports return on equity of -8.0%, an operating margin of 2.6% and revenue up 5.0% year over year.
Its debt exceeds its cash by 886.83M USD, a debt-to-equity ratio of 1.64. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 9 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 18.78 USD is 31.7% above the current price. The next earnings report is expected on 25 March 2027.